Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
NCT06839664

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

Led by Jiangsu Hansoh Pharmaceutical Co., Ltd. · Updated on 2025-02-21

610

Participants Needed

1

Research Sites

67 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.

CONDITIONS

Official Title

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 to 65 years at the time of consent
  • Body mass index (BMI) of 28 kg/m2 or higher, or BMI of 24 kg/m2 or higher with at least one of these comorbidities: prediabetes, hypertension, dyslipidemia, non-alcoholic fatty liver disease, obstructive sleep apnea
  • Weight change of 5.0% or less after diet and exercise control for at least 12 weeks before screening
Not Eligible

You will not qualify if you...

  • Diagnosis of diabetes mellitus
  • Weight change greater than 5.0% after diet and exercise control for at least 12 weeks before screening
  • Use of weight loss drugs within 3 months before screening
  • History of pancreatitis
  • Family or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
  • History of moderate to severe depression or serious mental illness
  • Any lifetime history of a suicide attempt
  • History of significant atopy, multiple or severe drug allergies, or severe posttreatment hypersensitivity reactions
  • History of any malignancy within the past 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University People's Hospital

Beijing, Beijing Municipality, China

Actively Recruiting

Loading map...

Research Team

C

Cuicui

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here